According to a new report, published by KBV research, The Global Market size is expected to reach $20.5 billion by 2031, rising at a market growth of 3.2% CAGR during the forecast period.
The Type 1 Diabetes segment generated the highest revenue in the Global Human Insulin Market by Indication in 2023; thereby, achieving a market value of $10.5 billion by 2031. Type 1 diabetes is an autoimmune condition that is defined by the immune system of the body attacking insulin-producing beta cells in the pancreas. This results in the pancreas releasing very little or no insulin at all.
The Pens segment is registering a CAGR of 2.8 % during the forecast period. The primary driver of the segment is insulin pens’ convenience and ease of use. Pre-filled with insulin, these pens eliminate the need for patients to draw doses from vials, reducing the likelihood of dosing errors and making the process less cumbersome.
The Rapid-acting insulin segment led the Global Human Insulin Market by Type of Insulin in 2023; thereby, achieving a market value of $6.3 billion by 2031. Rapid-acting insulins, such as insulin lispro, insulin aspart, and insulin glulisine, start working within minutes of injection and peak within an hour, making them highly effective for controlling blood sugar levels immediately after meals.
The Hospital Pharmacies segment is growing at a CAGR of 2.6 % during the forecast period. Hospitals are often the first point of contact for many patients diagnosed with diabetes, providing comprehensive care that includes initial diagnosis, treatment initiation, and management of complications.
Full Report: https://www.kbvresearch.com/human-insulin-market/
The North America region dominated the Global Human Insulin Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $7 billion by 2031. The Europe region is anticipated to grow at a CAGR of 2.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 3.8% during (2024 - 2031).
By Indication
By Product Type
By Type of Insulin
By Distribution Channel
By Geography
Unique Offerings 
